AYTU BIOPHARMA, INC

AYTU

$25M

Micro Cap

NASDAQPharmaceutical Preparations🇺🇸North AmericaDENVER82 employees

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

AYTU News

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

How AYTU's past catalysts played out

earningsMay 2024-8%earningsFeb 2024+5%earningsNov 2023+10%earningsOct 2023+8%earningsMay 2022-6%earningsFeb 2022-5%

Drug Pipeline

No drugs found in this phase.

📑

Catalyst DossierPRO

The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.

→

Market-Implied Move

Regulatory Approvals

Frequently asked questions

When is AYTU BIOPHARMA, INC's next FDA catalyst?→

CatalystAlert tracks every upcoming catalyst for AYTU BIOPHARMA, INC (AYTU) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track AYTU biotech catalysts?→

Add AYTU to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow AYTU BIOPHARMA, INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply